The court said that countries in Africa have been able to control the monkey population by importing the vaccine and it should be done in India also as it is in "larger public interest" and in "animals interest".
"Africa is importing the vaccine, why can't India do it? Africa has been able to control the monkeys' population," a bench of Acting Chief Justice Gita Mittal and Justice C Hari Shankar said.
The court appointed senior advocate Sanjay Jain, who earlier used to represent the Centre in the matter, as amicus curiae to assist it.
Meanwhile, the three municipal corporations also filed their status reports on the position of sterilisation of dogs and the court said it was necessary to have a report on the ground reality of the work undertaken by the civic bodies.
The bench had earlier directed the authorities to prepare a plan to control the increasing population of monkeys and dogs, known to have attacked people.
The court had also called for expediting the process of developing such a vaccine for immuno-contraception, which would use an animal's immune response to prevent pregnancy.
The court was hearing a PIL, filed through advocate Meera Bhatia, seeking directions to the authorities to take steps to deal with the menace of monkeys and dogs here.
Another plea by advocate Sumita Kapil, a south Delhi resident, claimed that a large number of dogs, pigs and monkeys were threatening the peacocks at the Deer Park there, causing them to leave the park and come out on the roads.
"The excreta of dogs and pigs are surely not helping in 'Swachh Bharat Abhiyan'," it had said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of 5 free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app